November 26, 2019
Alpha Tau Medical
Alpha DaRT™ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors.
Tel Aviv, Israel, November 26, 2019 – Alpha Tau Medical is pleased to announce the publication of the results of its first clinical trial of Alpha DaRT™, a...
January 3, 2019
Now going into clinical trials for specific types of cancer, Alpha Tau’s technology shows potential for treating any solid tumor.
By Brian Blum JANUARY 3, 2019, 8:00 AM
Alpha Tau is working toward commercializing its alpha radiation therapy technolog...
In the Media
Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and IFO
November 7, 2018
First Alpha Tau Medical Summit Gathers Over 200 Oncologists and Physicians From all Around the World!
March 23, 2018
Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices
April 11, 2019